Your browser doesn't support javascript.
loading
Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial.
Juraska, Michal; Early, Angela M; Li, Li; Schaffner, Stephen F; Lievens, Marc; Khorgade, Akanksha; Simpkins, Brian; Hejazi, Nima S; Benkeser, David; Wang, Qi; Mercer, Laina D; Adjei, Samuel; Agbenyega, Tsiri; Anderson, Scott; Ansong, Daniel; Bii, Dennis K; Buabeng, Patrick B Y; English, Sean; Fitzgerald, Nicholas; Grimsby, Jonna; Kariuki, Simon K; Otieno, Kephas; Roman, François; Samuels, Aaron M; Westercamp, Nelli; Ockenhouse, Christian F; Ofori-Anyinam, Opokua; Lee, Cynthia K; MacInnis, Bronwyn L; Wirth, Dyann F; Gilbert, Peter B; Neafsey, Daniel E.
Afiliación
  • Juraska M; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. Electronic address: mjuraska@fredhutch.org.
  • Early AM; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA.
  • Li L; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • Schaffner SF; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA.
  • Lievens M; GSK, Wavre, Belgium.
  • Khorgade A; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA.
  • Simpkins B; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • Hejazi NS; Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA, USA.
  • Benkeser D; Emory University Rollins School of Public Health, Department of Biostatistics and Bioinformatic, Atlanta, GA, USA.
  • Wang Q; Department of Statistics, University of Washington, Seattle, WA, USA.
  • Mercer LD; PATH, Seattle, WA, USA.
  • Adjei S; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Agbenyega T; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Anderson S; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA.
  • Ansong D; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • Bii DK; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Buabeng PBY; Kwame Nkrumah University of Science and Technology/Agogo Presbyterian Hospital, Agogo, Asante Akyem, Ghana.
  • English S; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA.
  • Fitzgerald N; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA.
  • Grimsby J; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA.
  • Kariuki SK; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Otieno K; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Roman F; GSK, Wavre, Belgium.
  • Samuels AM; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Kisumu, Kenya; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Westercamp N; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Ockenhouse CF; PATH, Seattle, WA, USA.
  • Ofori-Anyinam O; GSK, Wavre, Belgium.
  • Lee CK; PATH, Seattle, WA, USA.
  • MacInnis BL; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA.
  • Wirth DF; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA; Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, MA, USA.
  • Gilbert PB; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA; Department of Biostatistics, University of Washington, Hans Rosling Center for Population Health, Seattle, WA, USA.
  • Neafsey DE; Broad Institute, Infectious Disease and Microbiome Program, Cambridge, MA, USA; Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, MA, USA. Electronic address: neafsey@hsph.harvard.edu.
Lancet Infect Dis ; 24(9): 1025-1036, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38723650
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Vacunas contra la Malaria Límite: Female / Humans / Infant / Male País/Región como asunto: Africa Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Vacunas contra la Malaria Límite: Female / Humans / Infant / Male País/Región como asunto: Africa Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article